Kyoto, Japan

Eri Sanda

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Canon Kabushiki Kaisha. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eri Sanda: Innovator in Macrophage Identification Technology

Introduction

Eri Sanda is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of macrophage identification technology. Her innovative work focuses on developing methods and agents for identifying macrophage subtypes, which are crucial for various medical applications.

Latest Patents

Eri Sanda holds 1 patent for her invention titled "Macrophage identification agent, and identification method, sorting method, evaluation method, screening method and kit using the macrophage identifier agent." This patent aims to provide an identification method for macrophage subtypes using an organic compound. The invention includes a macrophage identification agent that exhibits different spectral characteristics depending on the macrophage subtype. This technology is essential for evaluating and screening macrophage subtypes in relation to test substances.

Career Highlights

Eri Sanda is currently employed at Canon Kabushiki Kaisha, where she continues to advance her research in macrophage identification. Her work has the potential to impact various fields, including immunology and drug development.

Collaborations

Eri has collaborated with notable colleagues such as Fumiyo Koide and Tsuyoshi Nomoto. Their combined expertise enhances the research and development of innovative solutions in the field.

Conclusion

Eri Sanda's contributions to macrophage identification technology exemplify her dedication to innovation in the medical field. Her work not only advances scientific understanding but also holds promise for future medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…